{
    "organizations": [],
    "uuid": "3dfe127d2feeeaa7a5cfb4f763997abd49b69687",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/15/the-associated-press-vical-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Vical reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Vical Inc. (VICL) on Thursday reported a loss of $3.7 million in its fourth quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 21 cents.\nThe drug developer posted revenue of $4 million in the period.\nFor the year, the company reported that its loss widened to $13 million, or $1.01 per share. Revenue was reported as $13.8 million.\nThe company's shares closed at $1.60. A year ago, they were trading at $2.33.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on VICL at https://www.zacks.com/ap/VICL",
    "published": "2018-03-15T13:47:00.000+02:00",
    "crawled": "2018-03-16T01:08:17.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "vical",
        "vicl",
        "thursday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "drug",
        "developer",
        "posted",
        "revenue",
        "million",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "company",
        "share",
        "closed",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "vicl",
        "http"
    ]
}